Ozurdex approved for non-infectious uveitis - ONA
Links shared publicly online about this topic.
- 840total visits
Ozurdex approved for non-infectious uveitis - ONA
View full resource at oncologynurseadvisor.com
Tags: Ulcerative Colitis Medication, FDA, Decadron, Dexamethasone Intensol, Dexpak Jr Taperpak, Dexpak Taperpak, Allergan
Most Recently Shared on September 28, 2010 at 6:07 pm By:
Ozurdex approved for non-infectious uveitis http://goo.gl/fb/ECaKn
Dexamethasone can be used to treat non-infectious uveitis - Ophthalmology Times Europe
oteurope.com — “Ozurdex (dexamethasone) can now be used for the treatment of inflammation of the posterior segment of the eye characterized as non-infectious uveitis” View full resource at oteurope.com
Most Recently Shared on April 27, 2011 at 12:33 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
News Update: Dexamethasone can be used to treat non-infectious uveitis http://ow.ly/1cmI32
Ozurdex approved for non-infectious uveitis - MPR
empr.com — “The FDA has approved Ozurdex (dexamethasone intravitreal implant, from Allergan) for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.” View full resource at empr.com
Most Recently Shared on September 28, 2010 at 5:20 pm By:
MPR News: Ozurdex approved for non-infectious uveitis: The FDA has approved Ozurdex (dexamethasone intravitreal im... http://bit.ly/9QhxHZ
FDA approves OZURDEX implant for uveitis treatment
news-medical.net — “Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.” View full resource at news-medical.net
Most Recently Shared on September 27, 2010 at 8:13 am By:
Obesity News: FDA approves OZURDEX implant for uveitis treatment: Allergan, Inc. today announced that the United S... http://bit.ly/9kS2e6
Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
agn.client.shareholder.com — “Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye” View full resource at agn.client.shareholder.com
Most Recently Shared on September 24, 2010 at 8:37 pm By:
eyeonfda Pharma and Health Lawyer
Allergan Gets FDA OK 4 OZURDEX(R) - Trtmnt Option 4 Non-Infectious Uveitis Affecting Posterior Segment of the Eye http://ow.ly/2JA4J
Advertisement
